Profile
Full Name
Regulus Therapeutics Inc.Ticker Symbol
RGLSExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
October 9, 2012Indexes
Not includedWebsite
http://www.regulusrx.comEmployees
34Key Details
Price
$2.06(+6.19%)
Market cap
$136.46M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
-
Annual EPS
-$0.82(+48.10% YoY)
PE ratio
-
Next earnings date
May 9, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Regulus Therapeutics doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Mar 27, 25 Wells Fargo
OverweightMar 17, 25 Canaccord Genuity
BuyFeb 26, 25 HC Wainwright & Co.
BuyNov 11, 24 HC Wainwright & Co.
BuyOct 30, 24 HC Wainwright & Co.
BuyAug 14, 24 Oppenheimer
OutperformAug 9, 24 HC Wainwright & Co.
BuyJul 16, 24 HC Wainwright & Co.
BuyJun 25, 24 HC Wainwright & Co.
BuyJun 25, 24 Canaccord Genuity
BuyInstitutional Ownership
- What is the ticker symbol for Regulus Therapeutics?
- Does Regulus Therapeutics pay dividends?
- What sector is Regulus Therapeutics in?
- What industry is Regulus Therapeutics in?
- What country is Regulus Therapeutics based in?
- When did Regulus Therapeutics go public?
- Is Regulus Therapeutics in the S&P 500?
- Is Regulus Therapeutics in the NASDAQ 100?
- Is Regulus Therapeutics in the Dow Jones?
- When was Regulus Therapeutics's last earnings report?
- When does Regulus Therapeutics report earnings?
- Should I buy Regulus Therapeutics stock now?
What is the ticker symbol for Regulus Therapeutics?
The ticker symbol for Regulus Therapeutics is NASDAQ:RGLS
Does Regulus Therapeutics pay dividends?
No, Regulus Therapeutics does not pay dividends
What sector is Regulus Therapeutics in?
Regulus Therapeutics is in the Healthcare sector
What industry is Regulus Therapeutics in?
Regulus Therapeutics is in the Biotechnology industry
What country is Regulus Therapeutics based in?
Regulus Therapeutics is headquartered in United States
When did Regulus Therapeutics go public?
Regulus Therapeutics's initial public offering (IPO) was on October 9, 2012
Is Regulus Therapeutics in the S&P 500?
No, Regulus Therapeutics is not included in the S&P 500 index
Is Regulus Therapeutics in the NASDAQ 100?
No, Regulus Therapeutics is not included in the NASDAQ 100 index
Is Regulus Therapeutics in the Dow Jones?
No, Regulus Therapeutics is not included in the Dow Jones index
When was Regulus Therapeutics's last earnings report?
Regulus Therapeutics's most recent earnings report was on Mar 13, 2025
When does Regulus Therapeutics report earnings?
The next expected earnings date for Regulus Therapeutics is May 9, 2025
Should I buy Regulus Therapeutics stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions